Back
GT Biopharma Vs. PTC Therapeutics Industry Stock Comparison
Sell
49
GTBP
GT Biopharma
Last Price:
2.03
Seasonality Move:
-3.67%
Sell
26
PTCT
PTC Therapeutics
Last Price:
35.07
Seasonality Move:
3.21%
Sell
49
GT Biopharma (GTBP)
is a Sell
Is GT Biopharma a Buy, Sell or Hold?
- The current GT Biopharma [GTBP] share price is $2.02. The Score for GTBP is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- GTBP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $35.10. The Score for PTCT is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- PTCT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GTBP Stock Price Chart
What is GT Biopharma's stock price today?
-
The GT Biopharma share price today is $2.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GTBP is experiencing slight selling pressure.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $35.10
The current trend is moderately bearish and PTCT is experiencing selling pressure, which indicates risk of future bearish movement.
GTBP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 42.95 | Sell |
Chaikin Money Flow: | -11804 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.03 - 2.19) | Sell |
Bollinger Bands (100): | (1.93 - 3.53) | Sell |
PTCT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.67 | Buy |
Relative Strength Index (14 RSI): | 49.33 | Sell |
Chaikin Money Flow: | -161832 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.77 - 36.79) | Buy |
Bollinger Bands (100): | (32.16 - 36.6) | Buy |
GTBP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.13 | Sell |
20-day SMA: | 2.12 | Sell |
50-day SMA: | 2.22 | Sell |
200-day SMA: | 3.86 | Sell |
8-day EMA: | 2.11 | Sell |
20-day EMA: | 2.13 | Sell |
50-day EMA: | 2.29 | Sell |
200-day EMA: | 4.74 | Sell |
PTCT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.48 | Sell |
20-day SMA: | 35.21 | Sell |
50-day SMA: | 33.99 | Buy |
200-day SMA: | 31.3 | Buy |
8-day EMA: | 35.99 | Sell |
20-day EMA: | 35.51 | Sell |
50-day EMA: | 34.53 | Buy |
200-day EMA: | 32.83 | Buy |
GT Biopharma Earnings Growth & GTBP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.43 per share, and a decrease next year of $0.00 per share.
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and an increase next year of $0.67 per share.
GT Biopharma Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
PTC Therapeutics Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |